EVP R&D, Chief Medical Officer
Wed, Jul 1, 2026
Jul 1
700 shares @ $52.13
Decreased holdings by -0.90%
77th largest trade (out of 157)
Planned (10b5-1)
“This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 56% above 200-day moving average